HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma

Fernanda Faião-Flores, Michael F. Emmons, Michael A. Durante, Fumi Kinose, Biswarup Saha, Bin Fang, John M. Koomen, Srikumar P. Chellappan, Silvya Stuchi Maria-Engler, Uwe Rix, Jonathan D. Licht, J. William Harbour, Keiran S.M. Smalley

Research output: Contribution to journalArticlepeer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences